In some people, Mounjaro’s effects appear within a few days to about a week as changes in appetite or feelings of fullness. Changes in body weight, on the other hand, are generally assessed over several weeks to a month, and changes in appearance over about 1 to 3 months. Some people notice a change in appetite on the day of the injection or the next day, but not feeling anything right away does not necessarily mean the medication is “not working.”
Mounjaro (generic name: tirzepatide) starts being absorbed after the injection. However, the time when blood levels rise, the time when appetite changes and the time when weight goes down are not the same. In this article, we explain “from which day it works” separately for how the drug behaves in the body, appetite, weight and appearance, based on the PMDA package insert revised in September 2026 and on clinical trials.
Key points firstIf you are busy, just read this section
- Day 1 to day 3: The medication is absorbed and blood levels rise. Some people notice changes in appetite or gastrointestinal symptoms.
- A few days to 1 week: Some people notice changes in appetite or fullness, such as feeling satisfied partway through a meal or snacking less.
- 2 to 4 weeks: If the change in how much you eat continues, a trend may start to show in your weekly average weight.
- 1 to 3 months: This is when it becomes easier to assess weight, waist circumference, how your clothes fit and so on together.
- If you notice no change on 2.5 mg: The first 4 weeks are at the starting dose. Do not increase the dose on your own; tell your doctor about your progress and any side effects.
When does Mounjaro start working? A timeline of what may happen and when
The answer depends on what you use to judge the “effect.” Absorption of the drug starts after the injection, but the order in which patients generally notice changes is “appetite and fullness” first, then “weight trend,” and after that “appearance and clothing size.”
| Timing | Possible changes | What to check |
|---|---|---|
| Injection day to day 3 | The drug is absorbed and blood levels rise. Some people experience nausea, an upset stomach or changes in appetite. | It is not abnormal if your weight does not drop right away. Check how severe any side effects are and whether you are drinking enough fluids. |
| 1 week | Some people feel satisfied partway through a meal or snack less. Others notice no change. | Record how much you eat, hunger, snacking and any gastrointestinal symptoms. |
| 2 to 4 weeks | If the change in how much you eat continues, a weight trend starts to appear. At the 2.5 mg starting dose, there may be no major change. | Compare weekly averages measured under the same conditions rather than day-to-day ups and downs. |
| 1 to 3 months | As dose adjustments and lifestyle changes add up, changes in weight and waist circumference become easier to see. | At your consultations, weight, waist circumference, physical condition, diet and test results are assessed together. |
| 3 to 6 months and beyond | Some people keep losing weight, while for others the pace slows down. | Do not increase the dose yourself just because of a plateau; review the benefits and risks of continuing treatment with your doctor. |
According to the PMDA package insert, in Japanese patients with type 2 diabetes the median time to peak blood concentration after repeated doses is about 24 hours, and the half-life is about 5 to 6 days. In another Japanese study, the median after the first dose was about 48 hours. However, peak blood concentration does not mean “the time when you lose the most weight” or that “weight drops at that moment.”
Why the drug’s action, appetite and weight do not change at the same time
Tirzepatide acts on GIP receptors and GLP-1 receptors. It promotes insulin secretion when blood sugar is high and slows the emptying of stomach contents. These actions change how much you eat, and when that continues, it shows up as a trend in your weight.
Pharmacological action:
Absorption starts after the injection, and the concentration in the body changes over several days.
Appetite and fullness:
Some people notice changes relatively early, but this is subjective and results vary.
Weight:
Weight fluctuates from day to day with fluids, bowel movements, salt intake, the menstrual cycle and so on, so it is assessed as a trend over a set period.
Changes in appearance and clothing:
You may notice these later than changes in weight.
Mounjaro and how to read weight-loss data
In Japan, the approved indication for Mounjaro is type 2 diabetes. Use for weight loss is self-pay treatment and off-label use. Zepbound, an obesity disease medication containing the same active ingredient, tirzepatide, has a different approved target population and conditions of use. When referring to clinical trial data on obesity disease, it is important not to confuse it with Mounjaro’s approved indication.
How long do Mounjaro’s effects last? When you feel you have “built up a tolerance”
Mounjaro is a long-acting medication given once weekly. According to the PMDA package insert, the half-life of tirzepatide is about 5 to 6 days. This means that one injection does not work at exactly the same strength for a whole week, and how you experience your appetite may change depending on how many days have passed since the injection.
In addition, the effect of slowing the emptying of stomach contents is most pronounced after the first dose and has been shown to weaken with 4 weeks of repeated dosing. Even if you feel less stomach bloating or strong fullness than right after starting, that alone does not mean “you have built up a tolerance to the drug” or “the effect has worn off.” Appetite, snacking, weekly average weight, waist circumference, blood sugar and so on are checked together.
When to talk to your doctor
If there is little change in appetite or weight, do not shorten the injection interval or increase the dose on your own. Instead, review the following with your prescribing doctor: (1) how long it has been since you started, (2) your injection technique, (3) meals and snacks, (4) constipation or swelling, (5) side effects and (6) other medications. The PMDA package insert states that for type 2 diabetes, a change of treatment should be considered if the effect is insufficient after 3 to 4 months of use.
Don’t panic if you feel Mounjaro 2.5 mg isn’t working
According to the Mounjaro package insert, for type 2 diabetes treatment starts at 2.5 mg once weekly, and the dose is increased to 5 mg once weekly after 4 weeks. 2.5 mg is the starting dose; it is the period for beginning treatment while checking for side effects and how you feel.
A strong loss of appetite or significant weight loss does not necessarily occur from the first dose. If you shorten the injection interval or increase the dose sooner than your doctor instructs because you see no change, the risk of nausea, vomiting, diarrhea, dehydration and so on increases.
Note that the dosage and administration in the package insert are for type 2 diabetes. When the medication is used for weight loss, too, the doctor decides on the prescription after checking effectiveness and safety at your consultation, rather than you deciding on your own.
What to check if you don’t feel Mounjaro working
Has it been only a short time since you started?
You cannot judge from your weight over just a few days or a week. First, also check for changes in appetite and how much you eat.
Are you weighing yourself under the same conditions?
Use the same conditions, such as after getting up and after urinating, and look at the weekly average rather than daily numbers.
Your intake, including drinks and snacks
Even if you eat less, weight loss may be harder to see if you consume more sugary drinks, alcohol, or foods that are high in calories even in small amounts.
Are you injecting correctly?
Check the injection site, technique, missed doses and how you store the medication. If you are unsure, consult your prescribing doctor.
Effects of constipation, swelling, menstruation, etc.
Even if you are losing fat, it may temporarily not show on the scale because of fluid levels or bowel movements.
Is the dose and treatment plan appropriate?
Your doctor assesses safety and effectiveness, taking into account any chronic conditions and other medications. Avoid increasing the dose on your own.
Even if the early response is small, some people lose weight later. In a post hoc analysis of SURMOUNT-1 and SURMOUNT-2 published in 2026, both the group that had lost 5% or more at week 8 and the group that had lost less than 5% achieved clinically meaningful weight loss at week 72. However, the early responders tended to achieve greater final weight loss.
In another post hoc analysis of SURMOUNT-1, among “slow responder” participants who had lost less than 5% at week 12, 90% achieved weight loss of 5% or more at week 72. This does not mean that everyone will lose weight if they continue long enough, but it supports not drawing conclusions about effectiveness from the numbers at or before week 8 or week 12 alone.
For more details, see also Characteristics of people for whom Mounjaro doesn’t work and what to check.
Not sure if it suits you? Start with a consultation.
A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.
No consultation fee (first & follow-up visits)Online consultation available
Weight changes with Mounjaro seen in clinical trials
Clinical trials compare weight and test results across groups at set time points, not the “day you noticed it” for each individual. Therefore, the data do not allow anyone to state that “you will lose X kg by day Y after the injection.”
| Source | Population and duration | What it shows |
|---|---|---|
| PMDA package insert (revised September 2026) | Clinical trials including Japanese patients with type 2 diabetes | Treatment starts at 2.5 mg and the dose is increased to 5 mg after 4 weeks. In Japanese patients after repeated doses, the median time to peak blood concentration was about 24 hours and the half-life was about 5 to 6 days. |
| SURPASS-2 exploratory analysis | Patients with type 2 diabetes | The median time to first achieve weight loss of 5% or more was 16.0 weeks with 5 mg and 12.4 weeks with 10 mg and 15 mg. These are not data for judging weight loss within a few days. |
| SURMOUNT-1 | Adults with obesity or overweight without diabetes, 72 weeks | Long-term weight loss was shown in the tirzepatide group combined with lifestyle intervention. Because this includes a 20-week dose escalation period, the final effect cannot be predicted from the short initial period alone. |
| SURMOUNT-J | Japanese patients with obesity disease, 72 weeks | Weight loss in the tirzepatide group was also shown in Japanese participants. However, these are average values from a clinical trial conducted under medical supervision and do not guarantee individual results. |
The SURMOUNT trials studied tirzepatide for obesity disease. Their results cannot simply be equated with how Mounjaro, which is indicated for type 2 diabetes in Japan, is used, or with each individual’s course when it is used as self-pay treatment.
Side effects to watch for right after starting and after dose increases
Gastrointestinal symptoms such as nausea, vomiting, diarrhea, constipation, abdominal discomfort and loss of appetite may occur when treatment starts or when the dose is increased. Do not put up with severe symptoms thinking “my appetite has dropped, so it’s working”; if you cannot eat or drink, contact your prescribing doctor.
Precautions confirmed in the PMDA package insert revised in September 2026
- If you are scheduled for surgery or a procedure involving general anesthesia or deep sedation, tell the medical staff in advance that you are using Mounjaro.
- Although a causal relationship has not been established, observational studies including similar drugs have reported a possible increased risk of non-arteritic anterior ischemic optic neuropathy (NAION). If you have any eye problems, such as a sudden loss of vision, seek medical care promptly.
| Symptoms | What to do |
|---|---|
| Persistent vomiting or diarrhea, unable to keep fluids down, passing little urine | There is a risk of dehydration or worsening kidney function. Consult a medical facility early. |
| Persistent severe abdominal pain with vomiting, or pain spreading to the back | This may be acute pancreatitis. Stop using the medication and seek medical care promptly. |
| Cold sweat, trembling, palpitations, strong hunger, feeling dazed | This may be hypoglycemia. Especially if you are also using insulin or a sulfonylurea (SU) drug, take the measures you were instructed to take in advance and consult a medical facility. |
| Unable to pass stool or gas, bloated abdomen, repeated vomiting | This may be a bowel obstruction (ileus). Seek medical care immediately. |
For side effects and precautions, please also see Mounjaro side effects and long-term precautions.
About self-pay treatment and off-label use
Frequently asked questions about when Mounjaro starts working
QDoes Mounjaro work from the first day or the next day?
The drug is absorbed after the injection, and data from Japanese patients show that blood levels become high about 1 to 2 days later. Some people notice a change in appetite on the first day or the next day, but not noticing anything does not necessarily mean the drug is not acting. Nor is there any guarantee that weight loss can be seen the next day.
QWhen do Mounjaro’s effects peak?
Blood levels of the drug become high about 24 to 48 hours after the dose, but this is not “the time when you lose the most weight.” Weight loss appears as dose adjustments and changes in diet and activity add up. Check short-term weight changes using weekly averages; the doctor assesses the treatment as a whole over a period of months.
QIs it OK if my weight doesn’t go down in the first week?
Weight over a single week is strongly affected by fluid levels and bowel movements. Record your appetite, how much you eat and how you feel, and compare weekly average weights measured under the same conditions. Discuss your progress with your prescribing doctor at the times they specify.
QHow many kg can I lose in a month with Mounjaro?
It is not possible to give a single figure for weight loss in one month. It varies with starting weight, dose, diet and exercise, physical condition and so on, and the first 4 weeks are also a period for your body to get used to the drug at the starting dose. Do not try to lose weight as if it were a race, and do not increase the dose on your own.
QWill I lose weight faster if the dose is increased to 5 mg?
A higher dose may increase not only the effect but also the side effects. Rather than increasing the dose just because the effect seems small, the doctor decides after checking gastrointestinal symptoms, how much you eat, blood sugar, other medications and so on.
QHow long does the effect of one injection last?
The half-life of tirzepatide is about 5 to 6 days, and the package insert specifies once-weekly dosing. Your appetite may feel different partway through the week, but do not shorten the injection interval on your own. If you miss a dose, follow the Drug Guide for Patients or your prescribing doctor’s instructions.
Not sure? Talk to us
No consultation fee (first & follow-up visits)Online consultation available
Toll-free 0120-241-929 (toll-free in Japan, 9:00–18:00 JST, Japanese only)
Summary: appetite changes first; judge weight by the trend over weeks to months
Mounjaro is absorbed after the injection, but changes in appetite and changes in weight do not appear at the same time. While some people notice a change in appetite within a few days to 1 or 2 weeks, weight is assessed by the trend from week 4 onward, and it is important not to decide it “doesn’t work” based only on early numbers.
Even if you feel the change is small, do not change the dose or injection interval on your own; review how much you eat, your injection technique, side effects and other medications with your prescribing doctor. At Hiro Clinic, a doctor checks your progress through online consultation and advises you on continuing treatment and on the dose.
References
- PMDA, “Mounjaro Subcutaneous Injection Ateos: package insert” (revised September 2026, 11th edition)
- PMDA, “Drug Guide for Patients: Mounjaro”
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022.
- Ozeki A, et al. SURMOUNT-J trial. Lancet Diabetes Endocrinol. 2025.
- Weight reduction over time by early weight loss response: SURMOUNT-1 post hoc analysis. Diabetes Obes Metab. 2025.
- Tirzepatide efficacy according to early weight response: SURMOUNT-1 and SURMOUNT-2 post hoc analysis. Diabetes Obes Metab. 2026.
- Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide: SURPASS-2 and SURPASS-3 exploratory analysis. Diabetes Ther. 2023.
- Eli Lilly Japan, “Request regarding the appropriate use of medicines”
This article is based on the package insert, official materials and peer-reviewed papers as of September 20, 2026. Effects and side effects vary from person to person, and depending on the results of your consultation, we may not be able to prescribe the medication.



